Impact of the 13-valent Pneumococcal Conjugate Vaccine on Chronic Sinusitis Associated With Streptococcus pneumoniae in Children

Abstract

S. pneumoniae continues to represent an important pathogen in chronic sinusitis in children <5 years of age. After the introduction of PCV13, S. pneumoniae isolation declined in children with chronic sinusitis at Texas Children's Hospital. We also observed a substantial reduction of PCV13 serotypes, predominantly serotype 19A.